MYOS RENS Technology Inc (NASDAQ:MYOS) Director Zhengguang Lyu acquired 50,000 shares of the company’s stock in a transaction dated Friday, September 23rd. The stock was bought at an average cost of $1.70 per share, for a total transaction of $85,000.00. Following the completion of the transaction, the director now directly owns 83,505 shares of the company’s stock, valued at $141,958.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Zhengguang Lyu also recently made the following trade(s):
- On Tuesday, September 6th, Zhengguang Lyu acquired 23,505 shares of MYOS RENS Technology stock. The stock was bought at an average cost of $1.60 per share, for a total transaction of $37,608.00.
MYOS RENS Technology Inc (NASDAQ:MYOS) opened at 1.75 on Thursday. The company’s market capitalization is $8.89 million. The stock has a 50 day moving average of $1.70 and a 200 day moving average of $1.80. MYOS RENS Technology Inc has a 12 month low of $1.23 and a 12 month high of $4.40.
MYOS RENS Technology Company Profile
MYOS RENS Technology Inc (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity.
Receive News & Ratings for MYOS RENS Technology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYOS RENS Technology Inc and related companies with MarketBeat.com's FREE daily email newsletter.